{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:32:15Z","timestamp":1790987535926,"version":"4.1.0"},"reference-count":112,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Portal vein thrombosis (PVT) is one of the common complications of cirrhosis. The incidence of PVT correlates with liver disease severity\u2014higher incidence in patients with Child\u2013Turcotte\u2013Pugh (CTP) C, large spontaneous portosystemic shunts, hepatofugal portal flow, and in the presence of hepatocellular carcinoma. PVT may worsen ascites, increase the risk and poor control of variceal bleeding. The occurrence of PVT may increase morbidity and lower survival after a liver transplant. Using statins prevents the occurrence of PVT, whereas beta-blockers may aggravate its occurrence. Cross-sectional imaging is mandatory for the precise diagnosis and classification of PVT. Symptomatic, occlusive PVT and candidacy for liver transplantation are the main indications for anticoagulation. Vitamin K antagonists, low-molecular-weight heparin, and newer anticoagulants are effective and safe in cirrhosis. Direct-acting oral anticoagulants are agents of choice in early cirrhosis (CTP A, B). The duration of anticoagulant therapy, predictors of response, and management of complications of cirrhosis while on therapy require in-depth knowledge and individualized treatment. Transjugular intrahepatic porto-systemic shunt can be considered in nonresponsive cases or when anticoagulants are contraindicated. This manuscript reviews the latest updated knowledge about managing PVT in cirrhosis.<\/jats:p>","DOI":"10.1055\/s-0044-1791247","type":"journal-article","created":{"date-parts":[[2024,10,4]],"date-time":"2024-10-04T22:55:24Z","timestamp":1728082524000},"page":"416-429","source":"Crossref","is-referenced-by-count":9,"title":["Management of Portal vein Thrombosis in Cirrhosis"],"prefix":"10.1055","volume":"44","author":[{"given":"Babu Lal","family":"Meena","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,10,4]]},"reference":[{"issue":"08","key":"ref1","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1055\/s-0038-1666861","article-title":"Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference","volume":"118","author":"N M Intagliata","year":"2018","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/liv.13500","article-title":"Decreased portal vein velocity is predictive of the development of portal vein thrombosis: a matched case-control study","volume":"38","author":"J G Stine","year":"2018","journal-title":"Liver Int"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/HEP.0000000000000538","article-title":"Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC","volume":"79","author":"M Senzolo","year":"2024","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejim.2022.05.032","article-title":"Epidemiology of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"104","author":"J Pan","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ueg2.12098","article-title":"Hepatic vein tumor thrombosis in patients with hepatocellular carcinoma: prevalence and clinical significance","volume":"9","author":"A M\u00e4hringer-Kunz","year":"2021","journal-title":"United European Gastroenterol J"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1007\/s00261-021-03270-x","article-title":"Tumor in vein (LR-TIV) and liver imaging reporting and data system (LI-RADS) v2018: diagnostic features, pitfalls, prognostic and management implications","volume":"46","author":"R Catania","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1478-3231.2006.01269.x","article-title":"Consensus on extra-hepatic portal vein obstruction","volume":"26","author":"S K Sarin","year":"2006","journal-title":"Liver Int"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/1751-2980.12970","article-title":"Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai)","volume":"22","author":"Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association","year":"2021","journal-title":"J Dig Dis"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.trre.2014.01.003","article-title":"Portal vein thrombosis and liver transplantation: implications for waiting list period, surgical approach, early and late follow-up","volume":"28","author":"F R Ponziani","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: a question of attribution","volume":"143","author":"C N Bagot","year":"2008","journal-title":"Br J Haematol"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4254\/wjh.v14.i4.682","article-title":"Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: what is the evidence?","volume":"14","author":"M Biolato","year":"2022","journal-title":"World J Hepatol"},{"issue":"01","key":"ref12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11239-014-1124-z","article-title":"Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis","volume":"40","author":"B Saugel","year":"2015","journal-title":"J Thromb Thrombolysis"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ajh.21335","article-title":"Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms","volume":"84","author":"A Fiorini","year":"2009","journal-title":"Am J Hematol"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study","volume":"104","author":"K K S\u00f8gaard","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12072-019-09951-6","article-title":"Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis","volume":"13","author":"X Xu","year":"2019","journal-title":"Hepatol Int"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/apt.15137","article-title":"Nonselective beta-blockers and the risk of portal vein thrombosis in patients with cirrhosis: results of a prospective longitudinal study","volume":"49","author":"F Nery","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/liv.15009","article-title":"Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response","volume":"41","author":"M Mandorfer","year":"2021","journal-title":"Liver Int"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0033-1334144","article-title":"Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis","volume":"39","author":"F Violi","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"05","key":"ref20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jhep.2017.07.002","article-title":"Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis","volume":"67","author":"R Carnevale","year":"2017","journal-title":"J Hepatol"},{"issue":"09","key":"ref21","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.3390\/ijms24097732","article-title":"Plasma antithrombin III levels can be a prognostic factor in liver cirrhosis patients with portal vein thrombosis","volume":"24","author":"T Suda","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"04","key":"ref22","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.32169","article-title":"Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus","volume":"75","author":"E G Driever","year":"2022","journal-title":"Hepatology"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"e00123","DOI":"10.14309\/ctg.0000000000000123","article-title":"Von Willebrand and factor VIII portosystemic circulation gradient in cirrhosis: implications for portal vein thrombosis","volume":"11","author":"M Praktiknjo","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V78.2.410.410","article-title":"Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells","volume":"78","author":"S Kapiotis","year":"1991","journal-title":"Blood"},{"issue":"08","key":"ref25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1136\/gutjnl-2019-319044","article-title":"Role of portal venous platelet activation in patients with decompensated cirrhosis and TIPS","volume":"69","author":"A Queck","year":"2020","journal-title":"Gut"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2009.03.013","article-title":"Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development","volume":"51","author":"M A Zocco","year":"2009","journal-title":"J Hepatol"},{"issue":"05","key":"ref27","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MEG.0000000000000325","article-title":"De-novo portal vein thrombosis in liver cirrhosis: risk factors and correlation with the model for end-stage liver disease scoring system","volume":"27","author":"A Abdel-Razik","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"H Maruyama","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref29","first-page":"e929844","article-title":"Nomogram model for prediction of portal vein thrombosis in patients with liver cirrhosis after splenectomy: a retrospective analysis of 2 independent cohorts","volume":"27","author":"H L Yuan","year":"2021","journal-title":"Med Sci Monit"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/jpm13010103","article-title":"Nomogram for predicting portal vein thrombosis in cirrhotic patients: a retrospective cohort study","volume":"13","author":"J Ding","year":"2023","journal-title":"J Pers Med"},{"issue":"12","key":"ref31","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/lt.25630","article-title":"Development of a model to predict portal vein thrombosis in liver transplant candidates: the portal vein thrombosis risk index","volume":"25","author":"D Gaballa","year":"2019","journal-title":"Liver Transpl"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.dld.2016.11.013","article-title":"Portal vein thrombosis: the role of imaging in the clinical setting","volume":"49","author":"C Margini","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2019.01.265","article-title":"Diagnosis, development, and treatment of portal vein thrombosis in patients with and without cirrhosis","volume":"156","author":"N M Intagliata","year":"2019","journal-title":"Gastroenterology"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL Clinical Practice Guidelines: vascular diseases of the liver","volume":"64","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu","year":"2016","journal-title":"J Hepatol"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1148\/radiology.154.3.3881793","article-title":"Portal thrombosis: dynamic CT features and course","volume":"154","author":"D Mathieu","year":"1985","journal-title":"Radiology"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s00261-007-9200-x","article-title":"Portal vein thrombosis: CT features","volume":"33","author":"H K Lee","year":"2008","journal-title":"Abdom Imaging"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1148\/radiol.2361030114","article-title":"The thread and streak sign","volume":"236","author":"B W Raab","year":"2005","journal-title":"Radiology"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2214\/ajr.168.3.9057522","article-title":"Benign and malignant portal vein thrombosis: differentiation by CT characteristics","volume":"168","author":"M E Tublin","year":"1997","journal-title":"AJR Am J Roentgenol"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/lt.25345","article-title":"Distinguishing tumor from bland portal vein thrombus in liver transplant candidates with hepatocellular carcinoma: the A-VENA Criteria","volume":"25","author":"C B Sherman","year":"2019","journal-title":"Liver Transpl"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00007890-200005150-00023","article-title":"Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome","volume":"69","author":"M A Yerdel","year":"2000","journal-title":"Transplantation"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","article-title":"Current knowledge and management of portal vein thrombosis in cirrhosis","volume":"75","author":"M Senzolo","year":"2021","journal-title":"J Hepatol"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"R de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"04","key":"ref43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1053\/j.gastro.2016.08.033","article-title":"Toward a comprehensive new classification of portal vein thrombosis in patients with cirrhosis","volume":"151","author":"S K Sarin","year":"2016","journal-title":"Gastroenterology"},{"issue":"03","key":"ref44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"R de Franchis","year":"2015","journal-title":"J Hepatol"},{"issue":"02","key":"ref45","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"L Loffredo","year":"2017","journal-title":"Gastroenterology"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"F Nery","year":"2015","journal-title":"Hepatology"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"M Senzolo","year":"2012","journal-title":"Liver Int"},{"issue":"03","key":"ref48","doi-asserted-by":"crossref","first-page":"E107","DOI":"10.1111\/hepr.12934","article-title":"Antithrombin III for portal vein thrombosis in patients with liver disease: a randomized, double-blind, controlled trial","volume":"48","author":"H Hidaka","year":"2018","journal-title":"Hepatol Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1097\/MEG.0000000000002123","article-title":"Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis","volume":"33","author":"S Xu","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"ref50","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.1007\/s10620-020-06695-4","article-title":"Safety, efficacy, and long-term outcomes of anticoagulation in cirrhotic portal vein thrombosis","volume":"66","author":"L Naymagon","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"A Luca","year":"2012","journal-title":"Radiology"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1016\/j.cgh.2020.02.037","article-title":"Prevalence and clinical significance of portal vein thrombosis in patients with cirrhosis and acute decompensation","volume":"18","author":"Y Zhang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/ajg.2012.313","article-title":"The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors","volume":"107","author":"L Amitrano","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis","volume":"31","author":"A Zanetto","year":"2018","journal-title":"Transpl Int"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e31826e8e53","article-title":"Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review","volume":"94","author":"K I Rodr\u00edguez-Castro","year":"2012","journal-title":"Transplantation"},{"issue":"02","key":"ref56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0b013e318206818b","article-title":"Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna","volume":"253","author":"M Ravaioli","year":"2011","journal-title":"Ann Surg"},{"issue":"02","key":"ref57","doi-asserted-by":"crossref","first-page":"e14520","DOI":"10.1111\/ctr.14520","article-title":"Meta-analysis and systematic review: prevalence, graft failure, mortality, and post-operative thrombosis in liver transplant recipients with pre-operative portal vein thrombosis","volume":"36","author":"J W Yeo","year":"2022","journal-title":"Clin Transplant"},{"issue":"05","key":"ref58","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jgh.16495","article-title":"Statin use in cirrhosis and its association with incidence of portal vein thrombosis","volume":"39","author":"W Amjad","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1217338","DOI":"10.3389\/fmicb.2023.1217338","article-title":"Potential contribution of the gut microbiota to the development of portal vein thrombosis in liver cirrhosis","volume":"14","author":"X Y Huang","year":"2023","journal-title":"Front Microbiol"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"E Villa","year":"2012","journal-title":"Gastroenterology"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12916-018-1069-8","article-title":"Transient portal vein thrombosis in liver cirrhosis","volume":"16","author":"X Qi","year":"2018","journal-title":"BMC Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"100593","DOI":"10.1016\/j.aohep.2021.100593","article-title":"Prevalence and characteristics of portal vein recanalization in cirrhotic patients admitted with portal thrombosis in a third level care center","volume":"27","author":"C A Campoverde-Espinoza","year":"2022","journal-title":"Annal of Hepatol"},{"issue":"10","key":"ref63","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/jgh.16263","article-title":"Natural history of portal vein thrombosis in cirrhosis: A systematic review with meta-analysis","volume":"38","author":"S Giri","year":"2023","journal-title":"J Gastroenterol Hepatol"},{"issue":"06","key":"ref64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.dld.2009.08.009","article-title":"Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study","volume":"42","author":"A De Santis","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"04","key":"ref65","doi-asserted-by":"crossref","first-page":"e00026","DOI":"10.14309\/ctg.0000000000000026","article-title":"Portal vein thrombosis in decompensated cirrhosis: rationale for treatment","volume":"10","author":"M Senzolo","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"07","key":"ref66","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cgh.2017.10.016","article-title":"Harmful and beneficial effects of anticoagulants in patients with cirrhosis and portal vein thrombosis","volume":"16","author":"V La Mura","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"07","key":"ref67","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"M G Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"08","key":"ref68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41424-018-0043-2","article-title":"Long-term outcome of splanchnic vein thrombosis in cirrhosis","volume":"9","author":"M Senzolo","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"01","key":"ref69","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12325-020-01550-4","article-title":"Anticoagulation favors thrombus recanalization and survival in patients with liver cirrhosis and portal vein thrombosis: results of a meta-analysis","volume":"38","author":"L Wang","year":"2021","journal-title":"Adv Ther"},{"issue":"02","key":"ref70","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41395-018-0421-0","article-title":"Clinical impact and safety of anticoagulants for portal vein thrombosis in cirrhosis","volume":"114","author":"I Pettinari","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis","volume":"79","author":"A Guerrero","year":"2023","journal-title":"J Hepatol"},{"issue":"54","key":"ref72","first-page":"2098","article-title":"Thrombolytic treatment of portal thrombosis","volume":"50","author":"P Malkowski","year":"2003","journal-title":"Hepatogastroenterology"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1148\/radiology.195.1.7892458","article-title":"Noncavernomatous portal vein thrombosis in hepatic cirrhosis: treatment with transjugular intrahepatic portosystemic shunt and local thrombolysis","volume":"195","author":"U Blum","year":"1995","journal-title":"Radiology"},{"issue":"05","key":"ref74","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/0284185115595060","article-title":"Endovascular treatment of acute and chronic portal vein thrombosis in patients with cirrhotic and non-cirrhotic liver","volume":"57","author":"K Rosenqvist","year":"2016","journal-title":"Acta Radiol"},{"issue":"41","key":"ref75","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.3748\/wjg.v23.i41.7470","article-title":"Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis","volume":"23","author":"T T Jiang","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"09","key":"ref76","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","author":"W Ageno","year":"2015","journal-title":"JAMA Intern Med"},{"issue":"01","key":"ref77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/MEG.0000000000001237","article-title":"A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis","volume":"31","author":"K I Rodriguez-Castro","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"01","key":"ref78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/TP.0000000000000785","article-title":"Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients","volume":"100","author":"M Ghabril","year":"2016","journal-title":"Transplantation"},{"issue":"07","key":"ref79","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2010.11.006","article-title":"Vascular disorders of the liver: recommendations from the Italian Association for the Study of the Liver (AISF) ad hoc committee","volume":"43","author":"M Senzolo","year":"2011","journal-title":"Dig Liver Dis"},{"issue":"01","key":"ref80","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2022.08.023","article-title":"Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis","volume":"78","author":"A Baiges","year":"2023","journal-title":"J Hepatol"},{"issue":"137","key":"ref81","first-page":"99","article-title":"Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin","volume":"22","year":"2013","journal-title":"Prescrire Int"},{"issue":"12","key":"ref82","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.3390\/jcm8122039","article-title":"Low dose low-molecular-weight heparin for thrombosis prophylaxis: systematic review with meta-analysis and trial sequential analysis","volume":"8","author":"R J Eck","year":"2019","journal-title":"J Clin Med"},{"issue":"09","key":"ref83","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1538-7836.2012.04824.x","article-title":"Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis","volume":"10","author":"M Senzolo","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"J H Koh","year":"2022","journal-title":"Dig Liver Dis"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17474124.2024.2307575","article-title":"Comparative effectiveness of warfarin in cirrhotic patients with non-symptomatic portal vein thrombosis: a multicenter, randomized controlled trial","volume":"18","author":"S Lu","year":"2024","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"01","key":"ref86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"H Chen","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"08","key":"ref87","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/j.1538-7836.2005.01414.x","article-title":"Treatment of venous thromboembolism","volume":"3","author":"H R Buller","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"20","key":"ref88","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.3390\/cells11203214","article-title":"Anticoagulants: a short history, their mechanism of action, pharmacology, and indications","volume":"11","author":"M Heestermans","year":"2022","journal-title":"Cells"},{"issue":"10","key":"ref89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/MEG.0000000000001846","article-title":"Efficacy and safety study of direct-acting oral anticoagulants for the treatment of chronic portal vein thrombosis in patients with liver cirrhosis","volume":"32","author":"M H Ai","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"06","key":"ref90","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","author":"N M Intagliata","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"05","key":"ref91","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/liv.13285","article-title":"Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis","volume":"37","author":"A De Gottardi","year":"2017","journal-title":"Liver Int"},{"issue":"04","key":"ref92","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","author":"J Hum","year":"2017","journal-title":"Eur J Haematol"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12876-023-02960-8","article-title":"Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis","volume":"23","author":"H Zhou","year":"2023","journal-title":"BMC Gastroenterol"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/hepr.12895","article-title":"Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis","volume":"48","author":"Y Nagaoki","year":"2018","journal-title":"Hepatol Res"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2022.06.005","article-title":"Management of urgent invasive procedures in patients treated with direct oral anticoagulants: an observational registry analysis","volume":"216","author":"A Godon","year":"2022","journal-title":"Thromb Res"},{"issue":"11","key":"ref96","doi-asserted-by":"crossref","first-page":"e2240145","DOI":"10.1001\/jamanetworkopen.2022.40145","article-title":"Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: a systematic review and meta-analysis","volume":"5","author":"R Chaudhary","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"02","key":"ref97","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0039-1679934","article-title":"Direct-acting oral anticoagulants (DOACs) in cirrhosis and cirrhosis-associated portal vein thrombosis","volume":"39","author":"E M Weinberg","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"06","key":"ref98","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00228-024-03648-y","article-title":"Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data","volume":"80","author":"M ME Diesveld","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"issue":"18","key":"ref99","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2019.07.089","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease","volume":"74","author":"W Guo","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjmed.2019.01.006","article-title":"Anticoagulation therapy in patients with liver cirrhosis is associated with an increased risk of variceal hemorrhage","volume":"132","author":"R Sasso","year":"2019","journal-title":"Am J Med"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejim.2020.03.005","article-title":"Anticoagulation in thrombocytopenic patients with hematological malignancy: a multinational clinical vignette-based experiment","volume":"77","author":"A Leader","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"09","key":"ref102","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1097\/MEG.0000000000002227","article-title":"Baveno-VI clinical staging of cirrhosis under-estimates 5-year survival after variceal bleed in cryptogenic chronic liver disease patients in India","volume":"33","author":"A Goel","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"01","key":"ref103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"G Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"issue":"07","key":"ref104","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/liv.13728","article-title":"Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients","volume":"38","author":"M Bianchini","year":"2018","journal-title":"Liver Int"},{"issue":"03","key":"ref105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MEG.0000000000001522","article-title":"Safety of variceal band ligation in patients with cirrhosis and portal vein thrombosis treated with anticoagulant therapy: a retrospective study","volume":"32","author":"S Ponthus","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"05","key":"ref106","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MEG.0000000000001061","article-title":"Bleeding risk of variceal band ligation in extrahepatic portal vein obstruction is not increased by oral anticoagulation","volume":"30","author":"M Guillaume","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"11","key":"ref107","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","article-title":"Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis","volume":"99","author":"R Salem","year":"2015","journal-title":"Transplantation"},{"issue":"01","key":"ref108","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.tvir.2016.01.006","article-title":"Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations","volume":"19","author":"B Thornburg","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"issue":"01","key":"ref109","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/j.tvir.2016.01.005","article-title":"Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis","volume":"19","author":"M R Chamarthy","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"issue":"01","key":"ref110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/apt.15044","article-title":"Systematic review with meta-analysis: portal vein recanalisation and transjugular intrahepatic portosystemic shunt for portal vein thrombosis","volume":"49","author":"S G Rodrigues","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"03","key":"ref111","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","author":"Z Wang","year":"2016","journal-title":"Radiology"},{"issue":"03","key":"ref112","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10620-018-5427-3","article-title":"Management of non-tumoral portal vein thrombosis in patients with cirrhosis","volume":"64","author":"J G Stine","year":"2019","journal-title":"Dig Dis Sci"},{"issue":"08","key":"ref113","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"S B Cui","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1791247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T23:36:29Z","timestamp":1733355389000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1791247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,4]]},"references-count":112,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,12,4]]},"published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1791247","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,4]]}}}